Introduction

Biomarkers and Precision Medicine 2025 is an immersive event now in its 20th year, spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated programmes on Spatial Biology for Precision Medicine and Digital Pathology & AI. The event gathers leading experts from global pharmaceutical companies, pioneering biotech firms & startups, and leading academic & healthcare institutions, all contributing to various therapeutic areas and stages of drug development, clinical trials, and precision patient treatments. 

Built with industry experts in-mind, the conference programme highlights: 

• Panel Discussion: IVDR & LDT Regulations & Their Impact?  
• Panel Discussion: Biomarker Strategies and Pharma Companies: Lessons Learned Over the Last 10 Years  
• Panel Discussion: Addressing The Future Needs Of Spatial Multi-Omics?  
• Panel Discussion: Exploring The Application Of Spatial Technologies In Immunology & Oncology A 
• Panel Discussion: Building A Business Case For Digital Pathology  

Useful links

• Further event details More information about the event

Speakers

• Elena Miranda Director, Non Clinical Histology, United Kingdom
• Espen Walker Global Head Medical Diagnostics, AstraZeneca, United Kingdom
• Jeroen van der Laak Professor of Computational Pathology, Radboudumc , United Kingdom
• Marcus Otte Senior Director, Head of Clinical Biomarker and Technologies, United Kingdom
• Maria Orr Head of Precision Medicine and Biosamples, Early Oncology, A, United Kingdom
• Matt Brown Chief Scientific Officer, Genomics England, United Kingdom

---

Venue

QEII

QEII, QEII, Broad Sanctuary, London, SW1P 3EE, United Kingdom

Organised by

Precision Medicine by Oxford Global

Contact information

Rachel Wheble
Precision Medicine
Godstow Court, Minns Business Park, Botley, Oxford OX2 0JB
01865 248 455
Contact us by email

---